Medicare Enrolled
Dr. Piyush Patel, M.D.
Pulmonary Disease · Flint, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Piyush Patel is a pulmonary disease specialist in Flint, MI, with 21 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 1,438 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Patel received a total of $4,227 from 41 pharmaceutical and/or device companies across 163 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 25% volume in MI
$4,227 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,438
Medicare services
Top 25% in MI for pulmonary disease
Not available
Unique patients (not deduplicated)
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
568 | $94 | $125 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
257 | $169 | $375 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $86 | $140 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
79 | $62 | $90 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
76 | $37 | $95 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
75 | $27 | $115 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
75 | $41 | $95 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
64 | $135 | $235 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
25 | $280 | $612 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $60 | $100 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
24 | $25 | $50 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
15 | $80 | $650 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
13 | $67 | $325 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
13 | $11 | $50 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
11 | $55 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.9% high complexity
1.9% medium
97.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,227
Total received (2018-2024)
Avg $604/year across 7 years
Top 25% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
163
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,802
2023
$722
2022
$563
2021
$446
2020
$143
2019
$229
2018
$322
Payments by company (2024)
Cook Incorporated
$750
GlaxoSmithKline, LLC.
$266
Inspire Medical Systems, Inc.
$147
Amgen Inc.
$95
AstraZeneca Pharmaceuticals LP
$83
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
HARMONY BIOSCIENCES LLC
$66
Regeneron Healthcare Solutions, Inc.
$53
GENZYME CORPORATION
$53
Baxter Healthcare
$43
JAZZ PHARMACEUTICALS INC.
$39
Mylan Specialty L.P.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$28
Merck Sharp & Dohme LLC
$21
Astellas Pharma US Inc
$21
United Therapeutics Corporation
$20
Grifols USA, LLC
$13
Top 3 companies account for 64.5% of 2024 payments
All-time payments by company (2018-2024) ›
Cook Incorporated
$750
GlaxoSmithKline, LLC.
$676
AstraZeneca Pharmaceuticals LP
$393
Boehringer Ingelheim Pharmaceuticals, Inc.
$243
Regeneron Healthcare Solutions, Inc.
$161
Inspire Medical Systems, Inc.
$147
Amgen Inc.
$139
Intuitive Surgical, Inc.
$137
Philips Electronics North America Corporation
$125
Actelion Pharmaceuticals US, Inc.
$114
Insmed, Inc.
$95
Baxter Healthcare
$94
GENZYME CORPORATION
$86
United Therapeutics Corporation
$83
HARMONY BIOSCIENCES LLC
$83
Mylan Specialty L.P.
$71
Harmony Biosciences LLC
$69
Grifols USA, LLC
$69
Takeda Pharmaceuticals U.S.A., Inc.
$60
Jazz Pharmaceuticals Inc.
$52
JAZZ PHARMACEUTICALS INC.
$50
Shire North American Group Inc
$44
Gilead Sciences, Inc.
$41
Resmed Corp
$39
Boston Scientific Corporation
$35
Allergan Inc.
$34
Mallinckrodt Hospital Products Inc.
$34
Pulmonx Corporation
$33
Circassia Pharmaceuticals Inc
$33
Genentech USA, Inc.
$30
Axsome Therapeutics, Inc.
$26
Sunovion Pharmaceuticals Inc.
$25
Electromed, Inc.
$25
Alexion Pharmaceuticals, Inc.
$23
Merck Sharp & Dohme LLC
$21
Astellas Pharma US Inc
$21
Teva Pharmaceuticals USA, Inc.
$16
PFIZER INC.
$13
Mallinckrodt Enterprises LLC
$12
Vanda Pharmaceuticals Inc.
$12
ADVANCED RESPIRATORY, INC
$11
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · ACTHAR · AIRSENSE · AIRSUPRA · AREXVY · AVYCAZ · AirSense · Arikayce · BREZTRI · CHANTIX · CHARTIS CATHETER · CINQAIR · Cresemba · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · EXALT Model D · Esbriet · FASENRA · GENERAL - PULMONARY · GLASSIA · Hetlioz · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · WAKIX · Wakix · Wellcentive Undiv · XYWAV · Xyrem · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
17
County median income
$60,673
Nearest hospital to ZIP centroid (approximate)
MCLAREN FLINT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 25% in MI), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Patel performed 568 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $4,227 from 41 companies across 163 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other pulmonary diseases in Flint?
Dr. Patel's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Flint
Browse pulmonary diseases in Flint ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in MI
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in MI
Which MI pulmonary diseases receive the most from drug and device companies.
By company
Cook Incorporated Payments to Doctors
See all physicians who received payments from Cook Incorporated.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology